RxDoctor Payments Data

Phong Nguyen

Interventional Cardiology · Augusta, GANPI 1992233407

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (55.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Medtronic at 52.2% of the total. Reporting peaked in 2024 at $9,279 and has fallen 84.9% since, to $1,404 in 2025.

$12,728in general payments, 2019–2025

Across 106 payments — averaging $120.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Boston Scientific$2K
  • Abiomed$2K
  • Abbott$743
  • Penumbra, Inc.$441
  • Cvrx, Inc.$286
  • plus $1K from 22 others

What the payments were for

  • Grants$7,06355%
  • Travel & lodging$1,0158%
  • Food & beverage$4,28234%
  • Education$3693%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,728 in reported general payments places this provider in the 65th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia →

Other interventional cardiology in Augusta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →